Skip to main content
. 2011 Aug;49(8):2810–2817. doi: 10.1128/JCM.00517-11

Table 2.

Clonality of antimicrobial-resistant pneumococci isolated in 2006 and 2007, a high-PCV7-uptake eraa

Serotype-PFGE cluster No. (%) of isolates MLST PMEN clone No. of drug-resistant carriers who received PCV7b
P value
0 doses (n=86) 1-4 doses (n=152)
PCV7 serotypes
    6B-1 1 (0.4) 5217 1 0 0.183
    6B-2 1 (0.4) 315 Poland6BST315 0 1 0.451
    6B-3 1 (0.4) 469 1 0 0.183
    14-4 28 (11.1) 557 (SLV), 5219 (DLV), 4585 (SLV) Spain9VST156 8 16 0.763
    14-5 3 (1.2) 9 England14ST9 3 0 0.020
    14-ND 1 (0.4) 4584 0 1 0.451
    19F-6 17 (6.7) 179 (SLV) Portugal19FST177 8 9 0.330
    19F-7 2 (0.8) 88 1 0 0.183
    19F-8 2 (0.8) 5218 1 1 0.682
    23F-9 15 (6.0) 338 Colombia23FST338 13 2 <0.001
    23F-10 6 (2.4) 338 Colombia23FST338 3 1 0.102
    23F-11 1 (0.4) 81 Spain23FST81 1 0 0.183
Non-PCV7 serotypes
    3-12 1 (0.4) 180 Netherlands3ST180 1 0 0.183
    6A-13 5 (2.0) 490 2 3 0.856
    6A-14 1 (0.4) 395 0 1 0.451
    6C-15 3 (1.2) 2689 1 1 0.682
    6C-16 2 (0.8) 2185 1 1 0.682
    6C-17 11 (4.4) 3396 6 5 0.193
    6C-18 6 (2.4) 3396 1 5 0.315
    6C-19 4 (1.6) 3673 2 2 0.560
    11A-20 12 (4.8) 4582 5 6 0.510
    15A-21 33 (13.1) 2105 (SLV), 63 Sweden15AST63 7 24 0.092
    19A-22 24 (9.5) 276 (SLV), 4267 (SLV) Denmark14ST230 5 19 0.099
    19A-23 11 (4.4) 416 (DLV) Netherlands15BST199 3 8 0.531
    19A-24 7 (2.8) 4302, 5221 2 5 0.672
    19A-21 19 (7.5) 63 Sweden15AST63 2 15 0.029
    22F-25 1 (0.4) 433 1 0 0.183
    24F-26 7 (2.8) 230, 1708 (SLV) Denmark14ST230 0 7 0.043
    33F-27 7 (2.8) 717 0 7 0.043
    NT-28 9 (3.6) 344, 4586 (SLV) NorwayNTST344 3 6 0.858
    NT-29 2 (0.8) 344 NorwayNTST344 1 1 0.682
    NT-30 1 (0.4) 344 NorwayNTST344 0 1 0.451
    NT-31 1 (0.4) 344 NorwayNTST344 0 1 0.451
    NT-32 1 (0.4) 4583 1 0 0.183
    NT-33 2 (0.8) 1156 2 0 0.059
    NT-34 1 (0.4) 5220 (SLV) NorwayNTST344 0 0
    NT-35 1 (0.4) 344 NorwayNTST344 0 1 0.451
    NT-36 2 (0.8) 344 NorwayNTST344 0 2 0.285
a

ND, not determined; DLV, double-locus variant of prototype strain of PMEN clone. Boldface data indicate statistically significant differences.

b

For 14 carriers, information on PCV7 was not available.